UK BioNTech Cancer Care Partnership
Clinical trials run through a partnership between the NHS, the UK Government and BioNTech are now recruiting patients.
Find out about the clinical trials
Clinical trials of candidate immunotherapies, including cancer vaccine candidates, are recruiting patients with a range of cancers.
Find out about the clinical trials
Clinical trials of investigational immunotherapies, including cancer vaccine candidates, are recruiting patients with a range of cancers.
Find out about the clinical trials old vpl/vpm
Clinical trials of investigational immunotherapies, including cancer vaccine candidates, are recruiting patients with a range of cancers.
What are cancer vaccines?
BioNTech’s cancer vaccine candidates are in clinical development as a potential new way to treat cancer. They are designed to activate the body’s immune system to attack cancer.
What are cancer vaccines?
BioNTech’s cancer vaccine candidates are in clinical development as a potential new way to treat cancer. They are designed to activate the body’s immune system to attack cancer.
What are cancer vaccines? vpl
BioNTech’s cancer vaccine candidates are in clinical development as a potential new way to treat cancer. They are designed to activate the body’s immune system to attack cancer.
What are cancer vaccines?
BioNTech’s cancer vaccine candidates are in clinical development as a potential new way to treat cancer. They are designed to activate the body’s immune system to attack cancer.
Aiming to advance cancer treatment
The NHS and BioNTech are working together to bring clinical trials of candidate immunotherapies, including cancer vaccine candidates, to UK patients.
Aiming to advance cancer treatment
The NHS and BioNTech are working together to bring clinical trials of investigational immunotherapies, including cancer vaccine candidates, to UK patients.
Find out about the clinical trials
Clinical trials of investigational immunotherapies, including cancer vaccine candidates, are recruiting patients with a range of cancers.
Find out about the clinical trials
Clinical trials of investigational immunotherapies, including cancer vaccine candidates, are recruiting patients with a range of cancers.
What are cancer vaccines?
BioNTech’s cancer vaccine candidates are in clinical development as a potential new way to treat cancer. They are designed to activate the body’s immune system to attack cancer.
What are cancer vaccines?
BioNTech’s cancer vaccine candidates are in clinical development as a potential new way to treat cancer. They are designed to activate the body’s immune system to attack cancer.
Aiming to advance cancer treatment
The NHS and BioNTech are working together to bring clinical trials of investigational immunotherapies, including cancer vaccine candidates, to UK patients.
